QPPV.COM KNOWLEDGE ASSESSMENT

GVP Product- or Population-Specific Considerations III: Pregnancy and Breastfeeding

Test your understanding of the concepts covered by GVP Product- or Population-Specific Considerations III: Pregnancy and Breastfeeding.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A pregnancy exposure is reported with no adverse outcome documented. What is the most appropriate pharmacovigilance interpretation?

The case is irrelevant because no adverse reaction occurred The exposure proves the medicine is safe in pregnancy The exposure may still be valuable for understanding use and supporting future outcome assessment The case should be coded as a congenital anomaly of unknown type

Question 2 of 10 What is the most appropriate interpretation of a pregnancy outcome occurring after exposure to several medicines?

All medicines must be considered equally causal The product under review is automatically excluded because another medicine was taken Timing, duration, pharmacology and alternative explanations should be assessed for each exposure The outcome should be attributed to the medicine taken most recently

Question 3 of 10 Which sequence best represents a defensible pregnancy or breastfeeding safety assessment?

Identify outcome, attribute it to exposure, issue a contraindication, then collect details Identify exposure, characterise timing and clinical context, define the outcome, assess alternatives and evidence, characterise uncertainty, then determine action Collect every available data element, calculate a count, and treat the count as incidence Assess only the medicine's known pharmacology and disregard disease and background risk

Question 4 of 10 A medicine is suspected of reducing milk production, but no adverse event has been reported in the infant. Why is the observation still relevant?

Effects on lactation can affect maternal treatment decisions and infant nutrition independently of direct infant toxicity Only infant adverse reactions are within pharmacovigilance scope Reduced milk production demonstrates direct infant drug toxicity Lactation outcomes are relevant only if medicine is detected in infant plasma

Question 5 of 10 Which statement best describes the exposure model during breastfeeding?

The infant is exposed through breast milk, so maternal dose is irrelevant Detection of medicine in milk is equivalent to direct therapeutic dosing of the infant Clinical relevance depends on milk transfer, timing, infant intake, bioavailability and the infant's ability to handle the medicine Only maternal adverse reactions need to be assessed

Question 6 of 10 Several reports describe a similar neonatal outcome after exposure to the same medicine. What should the organisation do first?

Declare causality because the cases form a cluster Ignore the reports because the number is small Conduct a structured signal assessment considering expected frequency, reporting patterns and shared background factors Immediately impose a contraindication without further assessment

Question 7 of 10 A medicine is detected in breast milk, but no reaction is observed in the infant. What is the most appropriate conclusion?

The finding proves there was no clinically relevant infant exposure The finding proves the medicine is safe for all breastfed infants The result should be interpreted in light of infant dose, pharmacology, age, maturity and clinical follow-up The medicine must be contraindicated during breastfeeding

Question 8 of 10 Why can infant age and maturity change the significance of exposure through breast milk?

Older infants cannot absorb medicines orally Premature infants, neonates and older infants may differ in organ maturity, feeding volume and pharmacokinetic handling Infant age affects only the mother's dose, not infant risk All infants receive the same dose per kilogram from breast milk

Question 9 of 10 What determines the evidential value of a pregnancy registry?

The fact that it collects data prospectively, regardless of design Its inclusion criteria, comparator, follow-up, completeness and outcome ascertainment The number of medicines listed in the registry alone Whether all participants experienced an adverse outcome

Question 10 of 10 What is the primary purpose of proportionate follow-up of a pregnancy report?

To obtain every conceivable personal detail regardless of relevance To clarify exposure, timing, outcomes and clinically important alternative explanations To guarantee that every report has a favourable outcome To replace the need for population-level studies

QPPV.com

GVP Product- or Population-Specific Considerations III: Pregnancy and Breastfeeding

Cookie Settings